TTD

The article highlights the biggest gainers and losers in the S&P500 one hour before Tuesday's market close. It offers a snapshot of the day's most active stocks.

OptimizeRx has teamed up with The Trade Desk to expand its healthcare advertising reach. The partnership aims to streamline access to specialized healthcare audiences for life sciences advertisers.

Trade Desk shares fell 4% amid index-rebalance selling, while Magnite dropped 3% and AppLovin pulled back. The piece discusses how programmatic ad‑tech peers are being repriced.

The Trade Desk was downgraded after weak Q2 results, negative growth, and margin pressure from AI competition.

Expands programmatic access to 800,000 verified prescribers directly in the EHR workflow, making OptimizeRx’s point of care inventory directly available to advertisers using The Trade DeskWALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp.

Key Stats for The Trade Desk StockCurrent Price: $13. 92Target Price (Mid): ~$23Street Target (mean): ~$14Potential Total Return: ~65%Annualized IRR: ~12% / yearWhat Happened?The Trade Desk (TTD) has reached the point in a decline where the average analyst target no longer sits ahead of the price.

Bloomberg’s IQ Test features Eric Balchunas, Matt Kaufman, and Brittany Christensen competing in "Bloomberg ETF IQ".

AXT Inc. (NASDAQ:AXTI) extended its winning streak to a fifth straight day on Monday, surging by as much as 16.4 percent in intraday trading to $81.50, as investors resumed buying positions amid its official membership in the S&P 600 index. Effective on the same day, the listed firm officially joined the S&P 600 index alongside […]